-
The pharmacokinetics of lopinavir in HIV-infected adults receiving rifampicin with adjusted doses of lopinavir
-
Population pharmacokinetic modelling for dose optimization of esomeprazole to treat early-onset preeclampsia
-
Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma
-
The determination of β-endosulfan and endosulfan sulfate in human serum with dialkylphosphate metabolites as urinary markers using LC-MS/MS electrospray ionization
-
Determination of Rifapentine and 25-O-desacetyl Rifapentine from 100 µl human breastmilk by LC-MS/MS using protein precipitation and solid phase extraction
-
Pharmacokinetics of twice-daily versus once-daily dosing with granular slow-release para-aminosalicylic acid in adults on second-line anti-tuberculosis and antiretroviral treatment
-
Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
-
Prizidilol : analytical methods and in vitro metabolism by hepatic enzymes
-
A school-based intervention for improving malaria-related knowledge and practices in Maputo Province, Mozambique : a randomised controlled trial
-
Morbidity from antiretroviral metabolic effects in Africa: The Mama Study
-
Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa
-
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
-
Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
-
Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections
-
Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir
-
Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
-
Clinical, pharmacokinetic, and genetic determinants of change in serum creatinine among Southern Africans on dolutegravir based antiretroviral therapy
-
Comparison of three levels of ascertainment of antenatal medication use at Gugulethu Midwife Obstetric Unit
-
Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
-
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
-
Screening rare filamentous actinobacteria for novel antimycobacterial compounds
-
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
-
The development of practical psychopharmacological guidelines for the South African context
-
Self-Reported Antenatal Medicines Use Among Women Living with and Without HIV in Western Cape, South Africa: A Sub-Analysis of the B Positive Cohort Study
